Primaxin 250 MG Injection

RxCUI
1726207
RxNorm name
Primaxin 250 MG Injection
Display name
Primaxin 250 MG Injection
Full name
Primaxin 250 MG Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PRIMAXIN IVIMIPENEM AND CILASTATIN SODIUMMerck Sharp & Dohme LLCf41d8abd-7792-4918-1b93-bd83ea01955e2024-07-05Warnings, Adverse reactionsExact identifier
rxcui: 1726207

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f41d8abd-7792-4918-1b93-bd83ea01955ePrimaxin 250 MG InjectionSY34These highlights do not include all the information needed to use PRIMAXIN safely and effectively. See full prescribing information for PRIMAXIN. PRIMAXIN® (imipenem and cilastatin) for Injection, for intravenous use Initial U.S. Approval: 198520240705
f41d8abd-7792-4918-1b93-bd83ea01955ecilastatin 250 MG / imipenem 250 MG Injection [Primaxin]SBD34These highlights do not include all the information needed to use PRIMAXIN safely and effectively. See full prescribing information for PRIMAXIN. PRIMAXIN® (imipenem and cilastatin) for Injection, for intravenous use Initial U.S. Approval: 198520240705
f41d8abd-7792-4918-1b93-bd83ea01955ePrimaxin 250 MG InjectionPSN34These highlights do not include all the information needed to use PRIMAXIN safely and effectively. See full prescribing information for PRIMAXIN. PRIMAXIN® (imipenem and cilastatin) for Injection, for intravenous use Initial U.S. Approval: 198520240705